NIH-funded research R01 grant

Investigating how glucose transport affects Alzheimer's disease

Official title: Role of glucose transport in Alzheimer's disease pathogenesis

Funded at Univ of Arkansas for Med Scis · NIH-11054634 · Data updated 2026-11-12

This study is looking at how brain cells called astrocytes help supply sugar to nerve cells in people with Alzheimer's disease, using special mice that show similar symptoms, to see if problems with sugar delivery might be linked to memory loss.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Arkansas for Med Scis
NIH-funded
Lab location1 site (Little Rock, United States)
Project startApril 15, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$382,500
NIH project number5R01AG084473-03
Project IDNIH-11054634 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for Alzheimer's disease, particularly those with genetic factors such as the ApoE4 variant.

Less likely to help

Patients with Alzheimer's disease who do not have the ApoE4 genetic variant may not benefit directly from this research.

What this research studies

This research explores the role of glucose transport in Alzheimer's disease (AD) by examining how astrocytes, a type of brain cell, help deliver glucose to neurons. The study uses a genetically modified mouse model that mimics aspects of AD, particularly focusing on the effects of the beta-amyloid peptide on glucose regulation and brain function. Researchers will assess the function of glucose transport proteins in these mice to understand how disruptions in glucose delivery may contribute to memory decline associated with AD.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for improving glucose metabolism in the brains of Alzheimer's patients, potentially enhancing cognitive function.

How similar studies have gone: Previous research has shown that targeting glucose metabolism can have positive effects in models of neurodegenerative diseases, suggesting potential for success in this approach.

Where this research is happening

  • Univ of Arkansas for Med Scis
    Little Rock, United States
    Active

Researchers

  • Principal investigator: Barger, Steven W — Univ of Arkansas for Med Scis
  • Study coordinator: Barger, Steven W

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.